Insider trades
David P. Southwell, Director of PTC Therapeutics PTCT, has filed 0 purchases and 10 sales on the open market. The latest trade was on 01/02.
David P. Southwell
Director
- Company
- PTC Therapeutics PTCT
- First filing
- 23/01/09
- Trades
- 37 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- No record
- Last trade
- 01/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PTC TherapeuticsPTCT | Open-market sale | 25/09/09 | 25/09/11 | 12,000 sh | $58.34 | $700,080 | −41.6% |
RCKT | Open-market sale | 24/04/12–24/04/15 | 24/04/16 | 80,000 sh3 trades | $24.32avg. | $1,945,566.96 | −41.1% |
PTCT | Open-market sale10b5-1 plan | 23/04/17 | 23/04/19 | 11,429 sh2 trades | $51.03avg. | $583,175.13 | −52.1% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 23/03/31 | 23/04/04 | 2,571 sh | $50.05 | $128,678.55 | −19.7% |
PTCT | Open-market sale10b5-1 plan | 23/03/27 | 23/03/29 | 10,000 sh3 trades | $45.09avg. | $450,942.7 | −48.8% |
